Immediate Impact
1 by Nobel laureates 50 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Victor Elinoff being referenced
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Victor Elinoff | 206 | 254 | 238 | 9 | 452 | |
| Rob van Maanen | 278 | 378 | 304 | 18 | 473 | |
| M. Laseur | 120 | 89 | 74 | 11 | 415 | |
| R. G. CHOA | 41 | 152 | 58 | 14 | 436 | |
| Susan W. Andersson | 132 | 47 | 48 | 14 | 438 | |
| Michael L. Bernstein | 194 | 77 | 94 | 9 | 415 | |
| Michael Lieber | 61 | 226 | 287 | 8 | 443 | |
| Lisa Gravens‐Mueller | 197 | 192 | 96 | 12 | 470 | |
| Elaine L. Steere | 131 | 50 | 56 | 10 | 501 | |
| Joseph Wang | 220 | 412 | 328 | 8 | 454 | |
| Daniel Gennevois | 81 | 35 | 16 | 11 | 418 |
All Works
Loading papers...